FBL

Across TCGA pan-cancer cohorts, FBL Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated FBL data layer compared with 29 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher FBL Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated FBL expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, MESO, and LUSC are the cancer types where FBL Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	1.000	0.622	.020	12	view →
MESO	DFS	Median	III,IV	0.078	0.376	.012	9	view →
LUSC	DFS	Median	II,III,IV	0.199	0.748	.006	6	view →
KIRP	OS	Median	All	0.680	0.948	.039	4	view →
BRCA	DFS	Median	All	0.112	0.525	.005	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

FBL–UCEC (DFS)

Open the UCEC breakdown →